Johnson & Johnson (JNJ)
AI picks 3 must-have dividend stocks for 2024 H2
In an era where some investors prioritize stable income and reliable returns, artificial intelligence (AI) has identified three standout dividend stocks poised to shine in the latter half of 2024.
7 Diversified Income Powerhouses for Lifelong Cash Flow
Diversified income stocks are a smart choice for investors seeking lifelong cash flow. They offer a reliable stream of income from multiple sources and provide stability and growth potential in any market condition.
Johnson & Johnson: Remaining A Buy Despite Remaining Risks
Johnson & Johnson reported solid first quarter results and is also expecting mid-single digit growth for the full year. The company is facing risks right now, especially from the litigations due to the talc products, and breaking the support line is also a rather bearish sign. But the stock seems slightly undervalued at this point, and Johnson & Johnson is probably a good investment for investors seeking stability and a bond-like investment.
J&J (JNJ) Trades Below 200 & 50-Day Moving Averages: Buy the Dip?
A new investor should avoid buying J&J (JNJ) stock right now due to its legal troubles. However, those who already own the stock may stay invested as the company is generating decent sales growth.
Johnson & Johnson: Put Selling Can Yield A Potential 9.8% Return
Johnson & Johnson's underlying business has a stable long-term outlook and the stock has a low volatility profile, which makes it an ideal platform for selling put options. The company is trading at a highly attractive valuation, which provides a solid margin of error. Selling put options does sacrifice capital appreciation, but with a nearly 10% annualized yield on offer, this opportunity appears to be a win-win to us.
2 Unstoppable Dividend Stocks to Buy if There's a Stock Market Sell-Off
Dividends can boost your portfolio returns. Johnson & Johnson is a classic example of a value stock with a faithful dividend history.
Cancer victims lose bid to block proposed J&J talc bankruptcy
A federal judge on Friday rejected a bid by a group of cancer victims to block Johnson & Johnson from pursuing a proposed bankruptcy settlement of tens of thousands of lawsuits alleging the company's baby powder and other talc products contain cancer-causing asbestos.
Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.
Is Johnson & Johnson Stock a Buy?
Johnson & Johnson is trying a new approach to resolve thousands of outstanding talc lawsuits. The company's operations are growing in the mid-single digits, and investors can expect more of the same in the years ahead.
Johnson & Johnson (JNJ) Stock Declines While Market Improves: Some Information for Investors
Johnson & Johnson (JNJ) closed the most recent trading day at $147.19, moving -1.29% from the previous trading session.
Is Johnson & Johnson the Best Dividend Stock for You?
You can confidently buy and hold Johnson & Johnson indefinitely. Its steady, high-single-digit returns can stack up over time.
Two High Conviction Dividend Buys For This Upside-Down Market
FOMO is driving stock market decisions, especially with meme stocks like GameStop and high-flying AI stocks. That's why I prefer discounted dividend stocks over growth stocks, and highlight two picks that offer durable capital returns. Both names carry strong balance sheets, pay well-above market average dividend yields, and are trading at substantial discounts to their historical valuations.
